Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-24-000223
Filing Date
2024-11-05
Accepted
2024-11-05 16:11:53
Documents
90
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20240930.htm   iXBRL 10-Q 1487243
2 EX-10.1 a2024q310-qexhibit101.htm EX-10.1 58449
3 EX-10.2 a2024q310-qexhibit102.htm EX-10.2 58480
4 EX-10.3 a2024q310-qexhibit103.htm EX-10.3 16902
5 EX-31.1 a2024q310-qexhibit311.htm EX-31.1 10733
6 EX-31.2 a2024q310-qexhibit312.htm EX-31.2 10731
7 EX-32.1 a2024q310-qexhibit321.htm EX-32.1 6311
13 GRAPHIC vrtx-20240930_g1.jpg GRAPHIC 41237
  Complete submission text file 0000875320-24-000223.txt   9073073

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20240930.xsd EX-101.SCH 56452
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20240930_cal.xml EX-101.CAL 128678
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20240930_def.xml EX-101.DEF 271009
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20240930_lab.xml EX-101.LAB 706228
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20240930_pre.xml EX-101.PRE 518179
93 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20240930_htm.xml XML 1531709
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 241427588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)